Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingmei Hsu

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Hematology|November 4, 2024
Allogeneic Hematopoietic Stem Cell Transplantation After Solid Organ Transplantation in Patients With Hematologic Malignancies Managed With Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease ProphylaxisCharley Jang, Jingmei Hsu
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Chimeric Antigen Receptor T-cell Therapy for Acute Myeloid LeukemiaXia Bi, Jingmei Hsu, Mia Gergis, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Allogeneic Chimeric Antigen Receptor T Cells for Hematologic MalignanciesYang Yang, Xia Bi, Mia Gergis, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Chimeric Antigen Receptor T Cell Therapy For Solid TumorsJingmei Hsu, Yang Yang, Mia Gergis, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Chimeric Antigen Receptor T-cell Therapies in Lymphoma Patients with Central Nervous System InvolvementDongni Yi, Mia Gergis, Ghada Elgohary, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Next-Generation Chimeric Antigen Receptor T-cellsDongni Yi, Mia Gergis, Jingmei Hsu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2019
Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA AntibodiesHannah Choe, Usama Gergis, Jingmei Hsu, et al.
Blood|October 12, 2017
<i>Chd7</i> deficiency delays leukemogenesis in mice induced by <i>Cbfb-MYH11</i>Tao Zhen, Erika M Kwon, Ling Zhao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2020
Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic MalignanciesJingmei Hsu, Zhengming Chen, Tsiporah Shore, et al.
Blood Advances|May 10, 2023
PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantationA Samer Al-Homsi, Frank Cirrone, Stephanie Wo, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Hematology|November 4, 2024
Allogeneic Hematopoietic Stem Cell Transplantation After Solid Organ Transplantation in Patients With Hematologic Malignancies Managed With Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease ProphylaxisCharley Jang, Jingmei Hsu
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Chimeric Antigen Receptor T-cell Therapy for Acute Myeloid LeukemiaXia Bi, Jingmei Hsu, Mia Gergis, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Allogeneic Chimeric Antigen Receptor T Cells for Hematologic MalignanciesYang Yang, Xia Bi, Mia Gergis, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Chimeric Antigen Receptor T Cell Therapy For Solid TumorsJingmei Hsu, Yang Yang, Mia Gergis, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Chimeric Antigen Receptor T-cell Therapies in Lymphoma Patients with Central Nervous System InvolvementDongni Yi, Mia Gergis, Ghada Elgohary, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Next-Generation Chimeric Antigen Receptor T-cellsDongni Yi, Mia Gergis, Jingmei Hsu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 22, 2019
Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA AntibodiesHannah Choe, Usama Gergis, Jingmei Hsu, et al.
Blood|October 12, 2017
<i>Chd7</i> deficiency delays leukemogenesis in mice induced by <i>Cbfb-MYH11</i>Tao Zhen, Erika M Kwon, Ling Zhao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 1, 2020
Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic MalignanciesJingmei Hsu, Zhengming Chen, Tsiporah Shore, et al.
Blood Advances|May 10, 2023
PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantationA Samer Al-Homsi, Frank Cirrone, Stephanie Wo, et al.
Pageof 3